Nobutake Kimura

Title: Nobutake Kimura: Innovator in Glycoprotein Research

Introduction

Nobutake Kimura is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of glycoprotein research, particularly in the development of inhibitors for Helicobacter pylori colonization. With a total of 5 patents to his name, Kimura's work has implications for the prevention and treatment of peptic ulcers.

Latest Patents

One of Kimura's latest patents involves a glycoprotein that exhibits inhibitory activity against Helicobacter pylori colonization. This innovative glycoprotein specifically binds to urease and is isolated from bovine milk whey or chicken egg albumen through affinity chromatography. The glycoprotein effectively inhibits colonization, making it useful for preventing or treating diseases caused by such infections, including peptic ulcers. Another significant patent is a pharmaceutical composition that includes anti-urease antibodies obtained from immunized hens and an inhibitor of gastric acid secretion. This composition is designed to eliminate urease from the stomach, providing a potential treatment for peptic ulcers.

Career Highlights

Throughout his career, Nobutake Kimura has worked with various organizations, including Ghen Corporation. His research has focused on developing innovative solutions to combat infections that lead to gastrointestinal diseases.

Collaborations

Kimura has collaborated with notable individuals in his field, including Yoshikatsu Kodama and Faustino C Icatlo, Jr. These collaborations have contributed to the advancement of his research and the development of his patents.

Conclusion

Nobutake Kimura's contributions to glycoprotein research and his innovative patents highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in the treatment of peptic ulcers and related conditions.